Merit Medical Systems (Nasdaq:MMSI) announced that it launched the Ventrax delivery system for cardiac interventions.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

In the United States, obesity is estimated to cause between 280,000 and 374,000 deaths each year and more than $170 billion ...

SOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced the US commercial release of its Ventrax ...

If left untreated, aortic regurgitation can cause the left ventricle to become enlarged and lead to heart failure. "The key question was, if you put in a new aortic valve and prevent the leakage ...

Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...

The electrocardiogram is nearly always abnormal in patients with significant aortic stenosis. Eighty to ninety percent have evidence of left ventricular hypertrophy with repolarization abnormalities.

Objective In this study, the impact of regular training on left ventricle morphology in a group of athletes with bicuspid aortic valve (BAV) was evaluated. Design Longitudinal cohort study. A group of ...

Systems announced the US commercial release of its Ventrax Delivery System. The new delivery system is Merit’s latest ...